CRP and Hyperglycemia: The consensus statement adopts the approach of Jensen et al., by recommending that patients should first be categorized based on their inflammation status, which can be assessed by a combination of biochemical markers such as serum levels of albumin, prealbumin, C-reactive protein (CRP), or white blood cell count, and clinical signs of inflammation such as fever, hypothermia, or systemic inflammatory responses (e.g., tachycardia, hyperglycemia).